US Drug Recall Register

FDA Drug Recalls

1,709 recalls · Class III, newest first

Class III · Low risk Terminated

Lidocaine Ointment USP

Reason Failed Stability Specifications: product did not meet viscosity results.

Teligent Pharma, Inc. NDC 52565-008-14 D-0331-2021
Class III · Low risk Terminated

Metformin HCl Extended-Release Tablets

Reason Failed Moisture Limits: Out of specification for water content

Sun Pharmaceutical Industries INC NDC 62756-142-02 D-0325-2021
Class III · Low risk Terminated

Candesartan Cilexetil Tablets

Reason Failed Impurities/Degradation Specifications

Macleods Pharma Usa Inc NDC 33342-114-10 D-0329-2021
Class III · Low risk Ongoing

Distributed by: DocRx

Reason Labeling: Illegible label: Manufacturer received complaint of mis-alignment print of the printed dosing instructions on the blister card.

Asclemed USA Inc. dba Enovachem Pharmaceuticals D-0330-2021
Class III · Low risk Terminated

Lcl-2-0191

Reason An error occurred where the product was manufactured with Potassium Chloride instead of Potassium Phosphate.

Washington Homeopathic Products, Inc. D-0323-2021
Class III · Low risk Terminated

Sp-4

Reason An error occurred where the product was manufactured with Potassium Chloride instead of Potassium Phosphate.

Washington Homeopathic Products, Inc. D-0322-2021
Class III · Low risk Terminated

Macula Pellets Homeopathic Medicine

Reason An error occurred where the product was manufactured with Potassium Chloride instead of Potassium Phosphate.

Washington Homeopathic Products, Inc. NDC 58770-190-42 D-0321-2021
Class III · Low risk Terminated

Tremfya

Reason Temperature Abuse

Cardinal Health Inc. NDC 57894-640-01 D-0314-2021
Class III · Low risk Terminated

Romidepsin Injecton

Reason Failed Impurity/Degradation Specifications: Out-of-specifications results observed for impurities during stability testing.

Teva Pharmaceuticals USA NDC 0703-4004-01 D-0309-2021
Class III · Low risk Terminated

Menopur 75 IU

Reason Failed pH specifications: Out of Specification pH results for 0.9% Sodium Chloride, USP

Ferring Pharmaceuticals Inc NDC 55566-7501-2 D-0299-2021
Class III · Low risk Terminated

Cequa

Reason Subpotent

Sun Pharmaceutical Industries INC NDC 47335-506-96 D-0289-2021
Class III · Low risk Terminated

Methylprednisolone Tablets USP

Reason Labeling: Illegible label: Customer complaint received of mis-alignment print of the printed dosing instructions on the blister card.

Jubilant Cadista Pharmaceuticals, Inc. NDC 59746-001-03 D-0298-2021
Class III · Low risk Terminated

Atorvastatin Calcium Tablets

Reason Failed Impurities/Degradation Specifications:presence of ATV cyclo IP and FP, Dihydroxy epoxy and Dieto epoxy impurities

Dr. Reddy's Laboratories, Inc. NDC 55111-123-90 D-0291-2021
Class III · Low risk Terminated

Methacholine Challenge 5-Syringe Test Kits

Reason Temperature Abuse; labeled with the incorrect room temperature (15-25 ¿C) storage conditions rather than the correct refrigerated (2 - 8 ¿C) storage conditions

Edge Pharma, LLC NDC 05446-1600-05 D-0306-2021
Class III · Low risk Terminated

Betamethasone Dipropionate Ointment USP

Reason Failed Impurities/ Degradation Specifications - OOS for know impurity Betamethasone 17- propionate.

Teligent Pharma, Inc. NDC 63739-996-15 D-0340-2021
Class III · Low risk Terminated

Betamethasone Dipropionate Ointment USP

Reason Failed Impurities/ Degradation Specifications - OOS for know impurity Betamethasone 17- propionate.

Teligent Pharma, Inc. NDC 52565-019-51 D-0339-2021
Class III · Low risk Terminated

Betamethasone Dipropionate Ointment USP

Reason Failed Impurities/ Degradation Specifications - OOS for know impurity Betamethasone 17- propionate.

Teligent Pharma, Inc. NDC 52565-019-15 D-0338-2021
Class III · Low risk Terminated

Auryxia

Reason Failed Dissolution Specifications

Akebia Therapeutics dba Keryx Biopharmaceutials, Inc NDC 59922-0631-01 D-0260-2021
Class III · Low risk Terminated

Glycopyrrolate Injection

Reason Labeling; Label Mix-up; correctly labeled 2 mL vials were packaged into blister strips labeled for 1 mL vials

Accord Healthcare, Inc. NDC 16729-472-08 D-0250-2021
Class III · Low risk Terminated

Oseltamivir Phosphate for Oral Suspension

Reason Failed Impurities/Degradation Specifications; Out-of-specification test results observed for Impurity C at 9 month long-term stability time point.

Lupin Pharmaceuticals Inc. D-0247-2021
Class III · Low risk Terminated

Benzphetamine tablets

Reason Labeling: Label Mix-up: Bottle labeled as Benzonatate 100 mg capsules contained Benzphetamine 50 mg tablets and a bottle labeled as Benzphetamine 50 mg tablets contained Benzonatate 100 mg capsules.

Calvin Scott & Company, Inc. NDC 10702-0040-50 D-1123-2022
Class III · Low risk Terminated

Testosterone Cypionate Injection

Reason Incorrect Labeling: Incorrect lot number on secondary packaging

Sun Pharmaceutical Industries INC NDC 62756-015-40 D-0242-2021
Class III · Low risk Terminated

Phytonadione Tablets 5mg

Reason Failed Impurities/Degradation Specifications:Out of specification during the 24 month stability testing of Impurity D.

Bausch Health Companies, Inc. NDC 68682-170-30 D-0244-2021
Class III · Low risk Terminated

Mephyton

Reason Failed Impurities/Degradation Specifications:Out of specification during the 24 month stability testing of Impurity D.

Bausch Health Companies, Inc. NDC 0187-1704-05 D-0243-2021